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Objective: Delirium is associated with poor outcomes following acute hospitalization. 
A specialized delirium management unit, the Geriatric Monitoring Unit (GMU), was established. 
Evening bright light therapy (2000–3000 lux; 6–10 pm daily) was added as adjunctive treat-
ment, to consolidate circadian activity rhythms and improve sleep. This study examined whether 
the GMU program improved sleep, cognitive, and functional outcomes in delirious patients.
Method: A total of 228 patients (mean age = 84.2 years) were studied. The clinical characteristics, 
delirium duration, delirium subtype, Delirium Rating Score (DRS), cognitive status (Chinese 
Mini–Mental State Examination), functional status (modified Barthel Index [MBI]), and chemi-
cal restraint use during the initial and predischarge phase of the patient’s GMU admission were 
obtained. Nurses completed hourly 24-hour patient sleep logs, and from these, the mean total 
sleep time, number of awakenings, and sleep bouts (SB) were computed.
Results: The mean delirium duration was 6.7 ± 4.6 days. Analysis of the delirium subtypes 
showed that 18.4% had hypoactive delirium, 30.2% mixed delirium, and 51.3% had hyperactive 
delirium. There were significant improvements in MBI scores, especially for the hyperactive 
and mixed delirium subtypes (P , 0.05). Significant improvements were noted on the DRS 
sleep–wake disturbance subscore, for all delirium-subtypes. The mean total sleep time (7.7 from 
6.4 hours) (P , 0.05) and length of first SB (6.0 compared with 5.3 hours) (P , 0.05) improved, 
with decreased mean number of SBs and awakenings. The sleep improvements were mainly 
seen in the hyperactive delirium subtype.
Conclusion: This study shows initial evidence for the clinical benefits (longer total sleep time, 
increased first SB length, and functional gains) of incorporating bright light therapy as part of a 
multicomponent delirium management program. The benefits appear to have occurred mainly 
in patients with hyperactive delirium, which merits further in-depth, randomized controlled 
studies.
Keywords: sleep, delirium, function, elderly
Introduction
Delirium is a common and serious condition in older hospitalized patients. The 
prevalence in hospitalized elderly patients is as high as 50%, being present in 11%–24% 
of older patients at admission, with another 5%–35% developing delirium during 
admission.1,2 It is an indicator of severe underlying illness, necessitating early diagnosis 
and prompt treatment. Despite varying etiologies, delirium has a characteristic 
constellation of symptoms, suggesting a common neural pathway. Importantly, motor 
symptoms are core symptoms, associated with cognitive impairments and sleep 
disturbances.
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The usually cited factors for delirium include advanced 
age, preexisting cognitive impairment, serious  medical 
conditions, medications (such as benzodiazepines), 
environmental factors, and sleep deprivation. Attention and 
memory impairment have been observed after periods of 
total and partial sleep deprivation,3,4 suggesting a mechanis-
tic relationship between delirium and sleep deprivation that 
may be mediated through involvement of the cholinergic and 
dopaminergic systems, although direct relationship between 
the two remains to be fully elucidated. Most of the available 
literature on delirium and sleep have involved intensive care 
unit patients. Critically ill patients, especially older adults, 
are known to experience poor sleep quality, with severe 
sleep fragmentation and sleep architecture disruption.5,6
Delirium is associated with an increased need for nursing 
surveillance, greater hospital costs, and high mortality 
rates of 25%–33% during hospitalization and 35%–40% at 
1 year.7–12 In partial response to this, the Geriatric Monitor-
ing Unit (GMU) was developed in October 2010 at the Tan 
Tock Seng Hospital, Singapore, using an evidence-based 
approach incorporating specific interventions established 
to be beneficial for delirium care. The details of the GMU 
have been published previously.13 To summarize, the GMU 
incorporated specific measures from the following programs: 
(1) Delirium Room, which provides comprehensive medical 
care, with multidisciplinary team meetings, and employs 
behavioral and appropriate nonpharmacological strategies as 
first-line management in delirious patients,14 (2) the concept 
of structured core interventions from the Hospital Elder Life 
Program (HELP),15–22 and (3) bright light therapy to estab-
lish a healthy sleep–wake cycle, with appropriate timing to 
effectively shift an altered circadian sleep–wake cycle to 
the desired phase.
Bright light therapy has gained increasing attention 
in recent years, as a potential environmental modifier 
(zeitgeber) of circadian rhythms. Additionally, therapeutic 
benefits have been demonstrated in terminally ill patients,23 
as well as those with seasonal affective disorders.24 In elderly 
patients with advanced sleep phase syndrome, evening 
exposure to bright light daily has been demonstrated to be 
beneficial.25–31 This can be achieved using a bright light box 
of 1000–3000 lux or natural exposure to the sun for 1–2 hours 
daily in the late afternoon and early evening. The aim of 
bright light therapy is to establish healthy sleep–wake cycles. 
A recent study demonstrated the utility of light therapy in 
adjusting the rest–activity cycle and improving bed rest in 
postesophagectomy patients, with decreased occurrences of 
incident delirium.32 Since sleep deprivation may aggravate 
delirium, it was anticipated that delirious patients would 
benefit from modulation of their sleep–wake cycle, while in 
the GMU. The peaceful environment of the GMU (without 
potential disruption by other patients) would facilitate unin-
terrupted sleep at night, while structured core interventions 
(with therapeutic activities) aimed to keep patients engaged 
in the day.
This study examined the impact of the GMU as a mul-
ticomponent intervention on outcomes of sleep, cognitive, 
and functional performance, in acute, hospitalized delirious 
older adults.
Methods
Subjects
We recruited 228 delirious patients who had been admitted to 
the GMU, Department of Geriatric Medicine, Tan Tock Seng 
Hospital, Singapore between December 2010 to August 2012. 
The subjects were classified into a  hyperactive, hypoactive, 
and mixed delirium subtype, based on their activity patterns. 
A patient was deemed to have recovered from delirium if 
the Confusion Assessment Method (CAM)33 criteria were 
no longer met, with the diagnosis of recovery being sup-
ported by improvement in cognitive and/or delirium severity 
scores, based on the Delirium Rating Score–R98 (DRS-
R98)34 and CAM-severity scores as well as input from the 
multidisciplinary team.
Inclusion/exclusion
The admission criteria for the GMU included patients above 
65 years old who were admitted to the geriatric medicine 
department and assessed to have delirium (either on admis-
sion or incident delirium during hospital stay), established 
in accordance with the CAM. Patients were excluded if 
they had medical illnesses that required special monitoring 
(eg, telemetry for arrhythmias or acute myocardial infarc-
tion); were assessed to be dangerously ill, in a coma, or had a 
terminal illness; uncommunicative or diagnosed with severe 
aphasia; demonstrated severely combative behavior with high 
risk of harm; or had contraindications to bright light therapy 
(manic disorders, severe eye disorders, photosensitive skin 
disorders, or use of photosensitizing medications). Patients 
with respiratory or contact precautions, and those with verbal 
refusal of GMU admission by family/patient/attending 
physician were also excluded. Patients who were prematurely 
transferred out of the GMU (for reasons such as instability 
of medical conditions requiring intensive monitoring, or new 
requirement of contact precautions) were excluded from 
subsequent analysis.
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Ethics approval for the study was obtained from a National 
Healthcare Group domain specific review board (DSRB).
Procedure
The GMU consisted of a five-bed unit with a specific elder-
friendly room design and lower staff-patient ratios. In addition, 
core interventions adopted from the HELP program (standard-
ized protocols for managing cognitive impairment, sleep depri-
vation, immobility, visual impairment, hearing impairment, 
and dehydration) were systematically administered. Bright 
light therapy (2000–3000 lux) was administered via lights 
installed in the ceiling and turned on from 6–10 pm daily. 
Sleep hygiene principles were also practiced during patients’ 
GMU stay. All interventions were delivered in accordance 
with a semistructured protocol, by trained geriatric nurses in 
GMU, with full (100%) compliance achieved.
We collected data on patient demographics (age, gender, 
race, length of hospital stay [LOS]), duration of delirium [in 
days], the medical comorbidities and severity of illness (using 
a modified Charlson Comorbidity Index35 and modified 
Severity of Illness Index),36 and the precipitating causes of 
delirium. Cognitive status was assessed using a locally vali-
dated Chinese Mini–Mental State Examination (CMMSE)37 
and functional status using a modified Barthel Index (MBI),38 
both administered by a trained assessor during the initial 
and predischarge phases of the patient admission. The rate 
and frequency of chemical restraint use was reviewed. As 
the GMU was a mechanical restraint–free unit, none of 
the patients in the GMU were subject to physical restraint. 
To adjust for the different antipsychotics prescribed, we used 
chlorpromazine equivalence39 to assess the total antipsychotic 
usage during the admission and also charted the frequency 
of benzodiazepine use.
Cognitive assessment
All patients underwent a detailed cognitive evaluation by the 
consultant geriatrician (specializing in cognitive and memory 
disorders) upon admission to the GMU. A family member 
or other designated caregiver was routinely interviewed to 
establish the patient’s baseline cognitive functioning prior 
to the current admission. The medical records of all patients 
were reviewed to ascertain whether a diagnosis of demen-
tia had been previously established. In patients yet to be 
diagnosed, a diagnosis of dementia was made in the current 
admission if the corroborative history suggested presence 
of cognitive symptoms consistent with DSM-IV criteria for 
dementia40 of at least 6-months duration, in accordance with 
the standardized process for cognitive evaluation.41
Sleep data collection
Eight specially-trained GMU nurses completed hourly 
patient sleep logs during the subjects’ stay in the GMU, 
as part of routine clinical care. The total sleep time (TST), 
number of awakenings, number of sleep bouts (SB), and the 
length of each SB was computed from the 24-hour sleep log 
data on admission and discharge from the GMU.
Statistical analysis
We evaluated the clinical characteristics, cognitive assess-
ment scores, functional status, and the use of pharmacological 
agents for the entire cohort of GMU patients and com-
pared among delirium subtypes, using analysis of variance 
(ANOVA) with Bonferroni correction and Chi-square tests for 
the continuous and categorical variables, respectively. Sleep 
parameters for the whole group and delirium subtypes were 
computed and the differences in the sleep data on discharge 
and admission were compared using paired-sample t-tests. 
We additionally analyzed the sleep parameters, adjusted for 
comorbidities, delirium days, and chemical restraint use. 
Statistical significance was taken to be P , 0.05.
Statistical analyses were performed using SPSS 16.0 soft-
ware (SPSS, Inc, Chicago, IL, USA).
Results
Demographics
A total of 228 patients were included in the analyses. 
We excluded 16 subjects who failed screening criteria, 
26 subjects whose family members declined GMU admis-
sion, and 31 subjects who were prematurely transferred out 
of GMU due to their medical condition. There were no age, 
gender, or ethnic differences between the study group and 
those excluded from the analyses. The majority of patients 
had hyperactive delirium (n = 117), followed by mixed 
delirium (n = 69) and hypoactive delirium (n = 42). The 
mean age was 84.2 ± 7.4 years, and participants were pre-
dominantly female (56.4%) and of Chinese ethnicity (88.2%). 
There were no significant age, gender, or racial differences 
between the delirium subtypes (Table 1).
Patients with the hyperactive delirium subtype had sig-
nificantly fewer comorbidities compared with those with 
hypoactive and mixed delirium (mean Charlson Comorbidity 
Index score 1.9, 2.9, and 2.5, respectively). Those with hyper-
active delirium also had a significantly shorter mean duration 
of delirium (5.8 ± 3.1 days) compared with those with 
hypoactive and mixed delirium (7.3 ± 6.0 and 7.9 ± 5.6 days 
respectively). However, there were no significant differences 
in LOS across the delirium subtypes.
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There were no significant differences in the prevalence 
of background dementia or number of precipitating causes 
of delirium. Sepsis was the predominant precipitating 
cause of delirium (64%–73.9%) among the delirium 
subtypes.
CMMSE
Although there were significant differences in CMMSE 
scores among the delirium subtypes on admission and 
discharge, there was no significant difference in the extent 
of improvement on the CMMSE nor in any of the delirium 
Table 1 Clinical characteristics, cognitive and functional outcomes in GMU patients (n = 228) at baseline
Total 
(n = 228)
Hyperactive 
(n = 117)
Hypoactive 
(n = 42)
Mixed 
(n = 69)
Demographics
Age (mean ± SD) 84.2 (7.4) 83.6 (7.5) 84.9 (7.8) 84.7 (6.9)
Gender (male %) 43.4 42.7 47.6 42.0
race (Chinese %) 88.2 93.2 80.9 84.1
Comorbidities
Charlson Comorbidity Index score35 2.3 (1.6) 1.9 (1.3)+ 2.9 (2.20) 2.5 (1.6)*
Severity of Illness Index score36 2.0 (0.3) 2.1 (0.2) 2.0 (0.3) 2.0 (0.4)
Days of delirium 6.7 (4.6) 5.8 (3.1) 7.3 (6.0) 7.9 (5.6)*,#
Length of stay 15.1 (9.3) 13.9 (7.1) 15.0 (10.4) 16.6 (11.4)
Precipitating causes of delirium
number of precipitating causes, n (%) 
 Single precipitating cause 
 Two precipitating causes 
 More than two precipitating causes 
Type of precipitating cause, n (%) 
 Sepsis 
 Other medical cause 
 Postoperative 
 Other surgical cause
 
67 (29.4%) 
72 (31.6%) 
89 (39.0%) 
 
155 (68.0%) 
48 (21.1%) 
7 (3.1%) 
18 (7.9%)
 
34 (29.1%) 
38 (32.5%) 
45 (38.5%) 
 
75 (64.1%) 
28 (23.9%) 
4 (3.4%) 
10 (8.5%)
 
9 (21.4%) 
13 (31.0%) 
20 (47.6%) 
 
29 (69.0%) 
8 (19.0%) 
1 (2.4%) 
4 (9.5%)
 
24 (34.8%) 
21 (30.4%) 
24 (34.8%) 
 
51 (73.9%) 
12 (17.4%) 
2 (2.9%) 
4 (5.8%)
Cognitive status
Prior dementia diagnosis (%) 46.1 44.4 45.2 49.3
newly diagnosed dementia during admission (%) 30.3 33.3 33.3 23.1
Prior behavioral issues before admission (%) 25.1 27.4 9.8 30.4*
Initial CMMSE37 (/28) 5.8 (5.5) 6.9 (5.9)+ 4.3 (5.3) 4.9 (4.4)*
Last CMMSE (/28) 9.2 (6.6) 10.5 (6.4) 7.8 (7.2)++ 7.9 (6.0)*
Change in CMMSE (/28) 3.4 (5.5) 3.6 (5.2) 3.5 (6.6) 3.0 (5.3)
Initial CAM33 5.1 (2.0) 5.2 (2.5) 5.3 (1.2) 5.0 (1.2)
Last CAM 2.2 (1.2) 1.9 (0.9) 2.3 (1.3) 2.5 (1.4)
Change in CAM -2.9 (2.3) -3.2 (2.7) -3.0 (1.4) -2.4 (1.8)
Initial DrS severity34 (/39) 22.5 (5.8) 21.6 (6.3) 23.1 (5.6) 23.6 (4.7)
Last DrS severity (/39) 14.6 (6.1) 13.5 (95.5) 16.0 (7.0) 15.4 (6.3)*
Change in DrS severity (/39) -6.2 (6.3) -6.4 (5.8) -5.3 (6.2) -6.2 (7.1)
Initial DrS total (/46) 26.2 (6.1) 25.3 (6.5) 26.9 (5.7) 27.3 (5.4)
Last DrS total (/46) 16.3 (6.7) 15.2 (5.9) 17.8 (7.7) 17.2 (7.2)
Change in DrS total (/46) -11.6 (6.1) -11.7 (5.9) -10.9 (5.7) -11.8 (6.9)
Initial DrS subitem sleep–wake disturbance (/3) 1.9 (0.8) 1.8 (0.8) 1.9 (0.9) 1.9 (0.6)
Last DrS subitem sleep–wake disturbance (/3) 0.7 (0.8) 0.7 (0.8) 0.6 (0.7) 0.6 (0.9)
Change in DrS subitem sleep–wake disturbance (/3) -1.2 (1.1)** -1.1 (1.1)** -1.3 (0.9)** -1.4 (1.3)**
Functional scores
MBI38 admission (/100) 29.1 (24.1) 36.8 (25.9) 16.9 (18.7) 23.4 (19.2)*
MBI discharge (/100) 47.4 (26.1) 56.4 (22.5) 30.9 (26.3) 42.3 (25.7)*
Improvement in MBI scores 18.4 (18.1)** 19.6 (18.6)** 14.0 (2.5)** 19.0 (18.4)**
Pharmacological agent use
Chemical restraints (%) 39.5 47.9 9.5 43.5*
Total antipsychotic use (CPZ equivalent) 0.9 (1.6) 1.2 (1.6) 0 (0) 1.0 (1.7)
Benzodiazepine usage (%) 24.6 26.5 9.5 30.4
Notes: *AnOVA P , 0.05 across delirium subtypes; **paired sample t-test P , 0.05 for GMU cohort and specific delirium subtypes; +post hoc results (with Bonferroni 
correction) between hyperactive delirium and hypoactive delirium (P , 0.05); ++post hoc results (with Bonferroni correction) between hypoactive delirium and mixed 
delirium (P , 0.05); #post hoc results (with Bonferroni correction) between hyperactive delirium and mixed delirium (P , 0.05).
Abbreviations: AnOVA, analysis of variance; CAM, Confusion Assessment Method; CMMSE, Chinese Mini-Mental State Examination; CPZ, chlorpromazine; DrS, Delirium 
Rating Scale; GMU, Geriatric Monitoring Unit; MBI, modified Barthel Index; SD, standard deviation.
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indicators among the delirium subtypes upon further 
analyses.
Functional status
There was significant improvement in functional status 
(MBI) at discharge, especially in the hyperactive and 
mixed delirium subtype (19.6 ± 18.6 and 19.0 ± 18.4 for 
the hyperactive and mixed delirium subtypes, respectively, 
compared with 14.0 ± 2.5 for the hypoactive delirium sub-
type) (P , 0.05).
restraint and medication use
None of the subjects were physically restrained. There was 
decremental chemical restraint use across the hyperactive, 
mixed, and hypoactive delirium subtypes (47.9%, 43.5%, and 
9.5%, respectively) (P , 0.001). However, benzodiazepine 
use exhibited a different decremental trend across the mixed, 
hyperactive, and hypoactive delirium subtypes (30.4%, 
26.5%, and 9.5% respectively) (P = 0.23). (see Table 1).
Sleep
All delirium subtypes showed significant improvement in the 
DRS sleep–wake disturbance subscore at discharge (Table 1). 
The GMU cohort also exhibited significant improvement 
in sleep parameters at discharge from the GMU compared 
with baseline, with increased TST (7.7 ± 2.5 hours versus 
7.1 ± 2.9 hours) (P , 0.01), increased length of first SB 
(5.9 ± 3.6 hours versus 5.3 ± 3.7 hours) (P , 0.01), decreased 
number of SB (1.57 ± 0.8 versus 1.59 ± 0.9) (P , 0.01), and 
fewer number of awakenings (0.6 ± 0.8 versus 0.7 ± 0.8) 
(P = 0.03) (see Figure 1). In the subgroup analyses of 
delirium subtypes, there was a significant increase in TST 
(7.4 ± 2.4 hours versus 6.7 ± 2.8 hours) (P , 0.01) and 
decreases in number of SB (1.6 ± 0.8 versus 1.7 ± 0.9) 
(P , 0.01) and length of first SB (5.7 ± 3.4 versus 4.9 ± 3.5) 
(P = 0.002) for hyperactive delirium subtype. For hypoactive 
delirium, there was a small but significant increase in TST 
(7.8 ± 3.1 hours versus 7.7 ± 2.7 hours) (P = 0.05) (see 
Table 2). However, upon adjustment for comorbidity, dura-
tion of delirium, and chemical restraint use, the differences 
were no longer statistically significant for any of the sleep 
parameters except length of SB in hypoactive delirium 
(Table 2).
Discussion
Our study contributes to the presently still limited literature 
on sleep outcomes following interventions in delirious older 
hospitalized adults, with demonstrated improvements in 
sleep and functional outcomes using bright light therapy as 
part of a multicomponent intervention program provided in 
the GMU.
We found significant improvements, with longer TST at 
night, increased length of the first SB, and decreased number 
of SBs and thus fewer awakenings in delirious older hospi-
talized adults admitted to the GMU. The sleep–wake distur-
bance measured on DRS-subscores also improved, indicating 
likely consolidation of sleep rhythms. This may be attributed 
to the increased physical activity, mental stimulation via 
reorientation, and structured activity programs in the day, 
along with evening bright light therapy as well as adherence 
to sleep hygiene principles during the GMU stay.
Of important clinical relevance were the short-term 
functional improvements, evident in the improvements 
achieved on MBI for all delirious subtypes, especially in 
the hyperactive delirium and mixed delirium subtypes. This 
will promote the geriatric management principles of early 
intervention and mobilization, and avoidance of physical 
restraint use, to prevent the complications of hospitaliza-
tion and immobility.42 The mean LOS of 15.1 ± 9.3 days 
in the acute hospital setting compares favorably with 
the 20.9 ± 2.1 days observed for delirious hospitalized 
older adults prior to the establishment of the GMU (point 
0
TST (hr) Sleep bout (hr) Sleep bouts Awakenings
Admission
Discharge
2
4
6
8
10
7.1
P = 0.00
P = 0.00
P = 0.00 P = 0.03
7.7 5.3 5.9 1.6 1.6 0.7 0.6
Figure 1 GMU patient sleep data (n = 228).
Abbreviations: GMU, Geriatric Monitoring Unit; TST, total sleep time.
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prevalence survey). The LOS was longer compared with that 
of US hospitals due to the funding, subvention structure, and 
models of geriatric care.
Interestingly, we noted phenomenological differences 
in delirious patients, where background dementia and 
behavioral issues prior to admission were more common 
in hyperactive and mixed delirium. This also related to 
the nonsignificant differences noted in sedative-hypnotic 
usage during the delirium episode. This interesting phe-
nomenon is yet to be fully understood in delirium, although 
Cunningham and MacLullich43 suggested delirium could 
be a maladaptive sickness behavioral response, with 
psychoneuroimmunological changes occurring with a 
systemic inflammation (for example infection) to manifest 
severe deleterious effects on brain function (during old age 
or in the presence of neurodegenerative disease). It was not 
unexpected that cognitive scores and DRS rating remained 
impaired despite a clinical impression of delirium resolution 
and adequate treatment of acute precipitating factors, thus 
supporting the concept of subsyndromal delirium,44 even in 
the resolution stage, and the findings of longer-term cognitive 
impairment following a delirium episode.
There were some limitations to this study. Since all 
patients were given the treatment protocol, there was 
no control group. These results need to be replicated in 
a randomized controlled study. Sleep parameters were 
collected via nurse observations through 24-hour sleep logs, 
with no objective data collected. However, this was a spe-
cialized unit with trained GMU nurses completing the sleep 
logs thus decreasing the risk of observer bias. We were not 
able to examine circadian activity rhythm changes without 
the use of wrist actigraphy and therefore could not ascertain 
whether this multicomponent program would restore rhythms 
in the delirious hospitalized elderly. Lastly, given that the 
interventions were performed on all the patients, with 100% 
compliance, we are not able to accurately delineate the ben-
efits of the individual components of this multicomponent 
intervention program.
In summary, we have demonstrated improvements in 
short-term outcomes related to improved function and sleep 
in delirious hospitalized older adults, in a real-life geriatric 
setting with bright light therapy as part of a multicompo-
nent delirium program. Longitudinal follow up of cognitive 
and sleep outcomes and further studies of pharmacologic 
agents that may help restore sleep and circadian rhythms 
in delirious hospitalized older adults and the delirium sub-
types would facilitate further understanding of this complex 
phenomenon.
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